Biotechnology Stocks I Performance Guide: Amylyx Pharmaceuticals, Inc. (AMLX)
AMLX has no dividends.
Table and Chart of AMLX Performance
See what a $1,000 investment in AMLX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| AMLX Returns | |
|---|---|
| Start Date | Feb-28-2022 |
| Start Price | $32.90 |
| End Date | Jul-26-2024 |
| End Price | $1.97 |
| # Prices | 30 |
| Min Date | May-31-2024 |
| Min Price | $1.72 |
| Max Date | Jan-31-2023 |
| Max Price | $39.19 |
| Total Return | -94.01% |
| Annualized Return | -67.57% |
| Current Value of $1,000 Purchase | $60 |
| Number Returns | 435 |
| Average Return | -13.63% |
| Number Profitable Returns | 124 |
| Percent Profitable Returns | 28.51% |
| Number Unprofitable Returns | 311 |
| Percent Unprofitable Returns | 71.49% |
| Profitable to Unprofitable Returns Ratio | 0.40 |
| AMLX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $133,971,000 |
| Beta | -0.639 | Price to Sales | 0.28 |
| Earnings per Share | $-1.0700 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 0.344 |
| PRICE DATA | |
| 52 Week High | $23.72 |
| 52 Week Low | $1.575 |
| Analyst Target Price | $4.25 |
| 50-Day Moving Average | $1.835 |
| 200-Day Moving Average | $9.16 |
| FINANCIAL DATA | |
| Revenue per Share | $5.89 |
| Revenue | $398,001,000 |
| Profit Margin | -17.9% |
| Return on Equity | -21% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
AMLX Compare Returns with S&P 500
AMLX Trendline Chart
AMLX Moving Average Chart
AMLX Stock Return Map - See Patterns of Gains and Losses
AMLX Stock Returns/Purchase Dates